Digital health, diagnostics and medical devices, and the signals that matter for adoption, reimbursement and outcomes.
Page 7 of 9
Mar 12, 2026The integration of AI into healthcare platforms is reshaping how patients interact with medical services. Amazon One Medical’s AI chatbot exemplifies this shift, serving as a front door to healthcare by interpreting lab results, answering medical inquiries, and facilitating care connections.
Mar 10, 2026The collaboration between Verily and Samsung represents a significant advancement in the integration of wearable health technology into the clinical trial landscape. Their joint effort focuses on utilizing Galaxy smartwatch data to enable remote patient monitoring and data analysis, potentially transforming the way pharmaceutical companies conduct studies and interpret trial results.
Mar 9, 2026With the integration of an AI-powered precision care platform, Presbyterian Healthcare Services aims to empower over 200 primary care providers, particularly benefiting rural patients who face long travel distances. The technology is designed to support faster, more accurate treatment decisions and maximize healthcare visit outcomes.
Mar 8, 2026Recent advancements in AI, signal processing, and digital health tools are creating unprecedented opportunities for the early detection and prevention of cardiac diseases, signifying a potential paradigm shift in cardiovascular healthcare.
Mar 2, 2026Health Gorilla, a health data aggregator, has filed a motion to dismiss a lawsuit brought by Epic Systems and several healthcare providers. The case centers on allegations regarding the inappropriate access to nearly 300,000 patient records and underscores the complexities in national health data sharing, governance, and regulatory frameworks.
Feb 22, 2026The integration of AI into nursing education is setting new standards for what is expected of graduating nurses. Early immersion in AI tools fosters adaptability and proficiency, empowering nurses to deliver high-quality care in technologically advanced healthcare environments.
Feb 21, 2026Mercyhealth’s integration of Arintra’s AI-powered medical coding solution has notably improved financial performance by streamlining coding automation, identifying documentation gaps, and customizing claims to specific payers, underscoring the transformative potential of AI in healthcare revenue cycles.
Feb 20, 2026The recent $10 billion acquisition of Masimo by Danaher marks a significant consolidation in the medical diagnostics sector. This strategic acquisition aims to enhance Danaher’s diagnostic capabilities and expand its footprint in acute care settings, highlighting an industry-wide shift towards integrated care and continuous clinical data collection inside hospitals.
Feb 19, 2026Patients navigating healthcare often face challenges with outdated or inaccurate lists of providers. The national provider directory, slated for launch this year, promises to centralize and standardize information about doctors and hospitals. This initiative could revolutionize healthcare navigation and decision-making for patients and providers alike.
Feb 12, 2026Mount Sinai’s decision to adopt Dragon Copilot highlights ongoing shifts in healthcare technology towards integrated AI solutions for clinical documentation. This move underscores the importance of interoperability and real-time ambient AI assistance in streamlining physician workflows.
Feb 5, 2026Jake Leach assumed leadership of DexCom with a mission to revitalize the company’s impact in diabetes management. He advocates that type 2 diabetics on GLP-1 weight loss drugs should also utilize CGMs, reflecting a growing intersection of diabetes technologies and therapies. This perspective highlights the evolving standards in diabetes care and DexCom’s innovative role within it.
Feb 3, 2026Dextrocardia is a rare congenital condition characterized by the heart and organs being reversed from their usual position. While rare, congenital heart defects are common and can vary in severity and impact. This article discusses the clinical perspectives on dextrocardia, its epidemiology, and implications for health.
Machine learning, predictive models and computational biology: how AI is changing discovery workflows and probability of success.
Drug development, clinical trials and industry dynamics. What changes timelines, risk and competitive positioning.
Gene therapy, CRISPR, synthetic biology and emerging platforms. Separating what is real from what is hype, and what actually translates.
Where capital is flowing and why the tape moves, across funding rounds, M&A, IPOs and market analysis.
FDA actions, approvals, policy shifts and compliance: how the rules change timelines and probability.